Skip to main content

Advertisement

SpringerLink
Log in

ASO Visual Abstract: Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I–III Breast Cancer

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Funding

Primary funding was provided by the Rob and Karen Hale Distinguished Chair in Surgical Oncology (to EAM), and additional funding for the project was provided by the Pam Gelsomini Fellowship Fund (to AL).

Author information

Authors and Affiliations

  1. Division of Breast Surgery, Department of Surgery, Brigham and Women’s Hospital, Boston, MA, USA

    Alison Laws MD, Ricardo Pastorello MD, Samantha Grossmith BA, Claire King BS, Monica McGrath BS, Elizabeth A. Mittendorf MD, PhD & Tari King MD

  2. Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA

    Alison Laws MD, Ricardo Pastorello MD, Samantha Grossmith BA, Stuart J. Schnitt MD, Elizabeth A. Mittendorf MD, PhD & Tari King MD

  3. Harvard Medical School, Boston, MA, USA

    Alison Laws MD, Tanujit Dey PhD, Stuart J. Schnitt MD, Elizabeth A. Mittendorf MD, PhD & Tari King MD

  4. Department of Pathology, Hospital Sirio Libanes, Sao Paulo, Brazil

    Ricardo Pastorello MD

  5. Department of Surgery, Center for Surgery and Public Health, Brigham and Women’s Hospital, Boston, MA, USA

    Tanujit Dey PhD

  6. Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA

    Stuart J. Schnitt MD

  7. Anne E. Dyson Professor of Surgery in the Field of Women’s Cancers, Dana-Farber Brigham Cancer Center, Harvard Medical School, Boston, MA, USA

    Tari King MD

Authors
  1. Alison Laws MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ricardo Pastorello MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tanujit Dey PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Samantha Grossmith BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Claire King BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Monica McGrath BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stuart J. Schnitt MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Elizabeth A. Mittendorf MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tari King MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tari King MD.

Ethics declarations

Disclosure

Tari King reports speakers honoraria and advisory board participation for Exact Sciences (formerly Genomic Health) and global advisory board participation for Besins Healthcare. Elizabeth A. Mittendorf reports clinical trial funding from Roche/Genentech (via an SU2C grant) and Gilead; compensated advisory board service for, and consulting fees from, Roche/Genentech, Merck, and Exact Sciences; compensated advisory board service for AstraZeneca; honoraria from Physicians’ Education Resource; and uncompensated service on the Board of Directors for the American Society of Clinical Oncology, the steering committees of Roche/Genentech, Bristol-Myers Squibb, and Eli Lilly, and uncompensated service as a Scientific Advisor for Susan G. Komen for the Cure Foundation. Alison Laws, Ricardo Pastorello, Tanujit Dey, Samantha Grossmith, Claire King, Monica McGrath, and Stuart J. Schnitt have no conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

A subset of these data was presented as a poster presentation at the ASCO Annual Meeting 2020: Laws A, Pastorello RG, Choi J, Kantor O, Grossmith S, Schnitt SJ, et al. The impact of pattern of tumor response and other post-treatment histologic features on local recurrence in patients treated with neoadjuvant chemotherapy and breast conservation. J Clin Oncol. 2020;38:15 Suppl:581. doi: 10.1200/JCO.2020.38.15_suppl.581.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Laws, A., Pastorello, R., Dey, T. et al. ASO Visual Abstract: Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I–III Breast Cancer. Ann Surg Oncol 29, 7737–7738 (2022). https://doi.org/10.1245/s10434-022-12165-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12165-0

Search

Navigation